About Acibadem Adana Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
BeiGene
3
Global Blood Therapeutics
3
Pfizer
3
Agios Pharmaceuticals, Inc.
2
Celgene
2
EMD Serono Research & Development Institute, Inc.
2
Hoffmann-La Roche
2
AlloVir
1
Baxalta now part of Shire
1
Daiichi Sankyo, Inc.
1
Immunic AG
1
Clinical Trials at Acibadem Adana Hospital
During the past decade, Acibadem Adana Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 3 clinical trials were completed, i.e. on
average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Avelumab in First-line NSCLC (JAVELIN Lung 100)
2015-10-29
2022-12-31
Active, not recruiting
1,214
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia
2016-05-02
2021-01-05
Completed
336
A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A
2015-11-12
2024-10-31
Active, not recruiting
120
Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
2015-12-24
2021-06-03
Completed
499
Comparison of Efficacy and Safety of Anti-PD-1 Antibody BGB-A317 Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With NSCLC
2017-11-30
2023-07-30
Active, not recruiting
805
A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenecity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients
2019-11-15
2023-12-01
Recruiting
500
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
2018-08-01
2024-09-01
Active, not recruiting
600
Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031
2018-06-06
2024-10-01
Active, not recruiting
179
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Acibadem Adana Hospital" #1 sponsor was "BeiGene" with 3 trials, followed by "Global Blood Therapeutics" with 3 trials
sponsored, "Pfizer" with 3 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored and "Celgene"
with 2 trials sponsored. Other sponsors include 9 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Acibadem Adana Hospital"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Acibadem Adana Hospital
According to Clinical.Site data, the most researched conditions in "Acibadem Adana Hospital" are
"Hemophilia A" (3 trials), "Hemophilia B" (3 trials), "Non-small Cell Lung Cancer" (3 trials), "Sickle Cell Disease" (3 trials) and "Vaso-occlusive Crisis" (2 trials). Many other conditions were trialed in "Acibadem Adana Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Acibadem Adana Hospital
Most popular intervention types in "Acibadem Adana Hospital" are "Drug" (23 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Cisplatin" (4 trials), "Capecitabine" (3 trials), "Carboplatin" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Acibadem Adana Hospital
The vast majority of trials in "Acibadem Adana Hospital" are
24 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Acibadem Adana Hospital
Currently, there are NaN active trials in "Acibadem Adana Hospital".
undefined are not yet recruiting,
15 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Acibadem Adana Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Acibadem Adana Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 24 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".